References

  1. Kanai I. introduction to Tuberculosis and Mycobacterium. South East- Asian Medical Information Centre Publication, International medical Foundation of Japan. 1990; 60:3-5. PubMed | Google Scholar

  2. World Health Organization. TB- A Global Emergence. Geneva :World Health Organization. 1994. Google Scholar

  3. World Health Organization (WHO). Stop TB Partnership. Tuberculosis Facts, Geneva. 2008. Google Scholar

  4. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-Associated Tuberculosis: the Epidemiology and the Response. Clin Infect Dis. 2010;50(3):201-7. PubMed | Google Scholar

  5. World Health Organization(WHO). Global tuberculosis control, surveillance, planning and financing. 2008. Google Scholar

  6. World Health Organization (WHO). Global Tuberculosis Control . 2011. Google Scholar

  7. Lönnroth K, Castro GK, Chakaya JM,Chauhan LS, Floy K, Glaziou P, Raviglione MC. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. 2010;375(9728):1755-7. PubMed | Google Scholar

  8. Federal Ministry of Health. General Directorate of Primary Health Care, Sudan. National Tuberculosis Control Programme. 2011. Google Scholar

  9. Muture B, Keraka M, Kimuu P, Kabiru E, Ombeka V, Oguya F. Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: a case control study. BMC Public Health. 2011;11:696:1-10. PubMed | Google Scholar

  10. Salla A, Simon A, Helen J S, Mark E, Atle F, Jimmy. Patient Adherence to Tuberculosis Treatment: a Systematic Review of Qualitative Research. PLoS Med. 2007;4(7):238. PubMed | Google Scholar

  11. Chuah SY. Factors associated with poor patient compliance with antituberculosis therapy in Northwest Perak, Malaysia. Tubercle. 1991 Dec;72(4):261-4. PubMed | Google Scholar

  12. Menzies R, Rochert I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis .Tuber& and Lung Disease. 1993Jun; 74(3):32-1. PubMed | Google Scholar

  13. Wilkinson D. High-compliance tuberculosis treatment programme in a rural community. Lancet. 1994 Mar;343(8898):647-48. PubMed | Google Scholar

  14. William J B, Cohn D L, Rietmeijer CA , Judson F N, SbarbaroJA, Reves RR. Noncompliance With Directly Observed Therapy for Tuberculosis: Epidemiology and Effect on the Outcome of Treatment. Chest. 1997 May; 111(5):1168-73. PubMed | Google Scholar

  15. Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, Daley CL. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. American Journal of Respiratory and Critical Care Medicine. 2004;170(5):561-6. PubMed | Google Scholar

  16. Amoran O E, Osiyale O O and Lawal K M. Pattern of default among tuberculosis patients on directly observed therapy in rural primary health care centres in Ogun State, Nigeria. Journal of Infectious Diseases and Immunity. 2011 May; 3(5): 90-95. PubMed | Google Scholar

  17. Suleiman M M A, Sodemann M. Evaluation of tuberculosis control programme in Khartoum State for the year 2006. Scandinavian Journal of Public Health. 2009;37(1):1018. PubMed | Google Scholar

  18. World Health Organization (WHO). Operational Guide for National Tuberculosis Control Programmes. 2002. Google Scholar

  19. Jochem K, Fryatt RJ, Harper I, White A, Luitel H, Dahal R. Tuberculosis control in remote districts of Nepal comparing patient-responsible short-course chemotherapy with long-course treatment. Int J Tuberc Lung Dis.1997;1(6):502-8. PubMed | Google Scholar

  20. Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to tuberculosis treatment. Bull World Health Organ. 2008;86(3): B-D. PubMed | Google Scholar

  21. Kate C C, Janet M B, Sarah E R , and Daniel P C. Movement of Tuberculosis Patients and the Failure to Complete Antituberculosis Treatment. American Journal of Respiratory and Critical Care medicine .1998; 157(4): 1249-52. PubMed | Google Scholar

  22. Nyi N N, Catherine D, Abdul Rahman I, Rosemi S, Noraini B and Mohd R M. Factors Contributing to Poor Compliance with Anti-TB Treatment among Tuberculosis Patients. South East Asian J Trop Med Public health. 2001 June;32 (2):369-382. PubMed | Google Scholar

  23. Tatek W, Kifle W, Wondwossen K, Sofonias G. Delay in Initiating Tuberculosis Treatment and Factors Associated among Pulmonary Tuberculosis Patients in East Wollega, Western Ethiopia. EthiopJHealth Dev. 2007;21(2):148-156. PubMed | Google Scholar

  24. Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T, Muniyandi M and Narayanan P R. Reasons for Non-Compliance among Patients Treated Under Revised Natoional Tuberculosis Control Programme (RNTCP), Tiruvallur District , South India. Indian J Tuberc. 2007 Jul; 54(3):130-135. PubMed | Google Scholar

  25. Samuel AB, Tomoko K, Tomoko T, Nobuyuki H. Factors Contributing to Tuberculosis (TB) Defaulter Rate in New Juaben Municipality in the Eastern Region of Ghana. Journal of the National Institute of Public Health. 2010; 59(3): 291-7. PubMed | Google Scholar

  26. Castelnuovo B. A review of Compliance to Anti Tuberculosis Treatment and Risk Factors for Defaulting Treatment in Sub Saharan Africa. African Health Sciences. 2010 Dec; 10(4): 320 - 324. PubMed | Google Scholar

  27. Kelly E D, Ouafae L, Iraqi G, Janine K, Diss E, Imad C, Rajae E. Risk Factors for Tuberculosis Treatment Failure, Default, or Relapse and Outcomes of Retreatment in Morocco. BMC Public Health. 2011; 11:140. PubMed | Google Scholar

  28. Alyssa F, Joey L, Timothy H H, Karin W, Abe M and Martie V D W. Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study. BMC Public Health. 2012 Jan 20; 12:56. PubMed | Google Scholar

  29. Fleiss L J. Statistical Methods for Rates and Proportions. -2nd ed. 1981; 35-48. Google Scholar

  30. Kelsey J L, Whittemore A S, Thomson W D and Evans A S. Methods in Observational Epidemiology-2nd ed. 1986. New York: Oxford University Press. Google Scholar

  31. Riegalman R K, and Hirsch R P. Studying a study and testing a test. How to read the medical literature -2nd ed. 1989. Boston: little , Brown and company, Waltham, Massachusetts. Google Scholar